Wholesale of pharmaceutical and medical goods
NORENGROS HX AS
Revenue 2024
NOK 33.5m
Operating profit
NOK −493,000
Equity
NOK 2.2m
Incorporated
2018
Employees
9
Share capital
NOK 3.0m
Key figures · 2024
Current ratio
1.20
Equity ratio
25.1%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -1.5% | |
| Net margin (%%) | -1.5% | |
| Return on assets (%%) | -5.5% | |
| Likviditet | ||
| Current ratio | 1.20 | |
| Working capital | 1.2m | |
| Soliditet | ||
| Equity ratio (%%) | 25.1% | |
| Debt-to-equity ratio | 2.99 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.